Shrinking lung syndrome in systemic sclerosis

E-ISSN： 1529-0131|48|10|2999-3000

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.48, Iss.10, 2003-10, pp. : 2999-3000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Interstitial Lung Disease in Systemic Sclerosis: Pathophysiology, Current and New Advances in Therapy

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 266-277

Bentham Science Publishers

Access to resources Recommend Favorite

Management of systemic sclerosis

By Ong Voon H Brough Geraldine Denton Christopher P

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 214-219

Royal College Of Physicians

Access to resources Recommend Favorite

Biologics in Systemic Sclerosis

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 549-557

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Fibrosis in Systemic Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 395-400

Bentham Science Publishers

Access to resources Recommend Favorite

Animal Models of Systemic Sclerosis

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2365-2379

Bentham Science Publishers

Access to resources Recommend Favorite